ELI LILLY & Co is 213.5x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($1.070 T vs $5.01 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | XENE | LLY |
|---|---|---|
| Market cap | $5.01 B | $1.070 T |
| US-listed rank | #1389 | #10 |
| Revenue (latest FY) | $7.50M | $65.18B |
| Net income (latest FY) | -$345.91M | $20.64B |
| Net margin | -4612.1% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 763 | 989 |
ELI LILLY & Co is 213.5x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($1.070 T vs $5.01 B).
In their latest fiscal years, Xenon Pharmaceuticals Inc. reported $7.50M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Xenon Pharmaceuticals Inc. and ELI LILLY & Co, or browse the full rankings.